602 related articles for article (PubMed ID: 19743725)
1. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
Thiboutot D; Eichenfield L; Shalita A; Del Rosso JQ; Swinyer L; Tanghetti E; Tschen E; Parr L
Cutis; 2009 Jul; 84(1):48-55. PubMed ID: 19743725
[TBL] [Abstract][Full Text] [Related]
2. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
Tanghetti E; Kircik L; Wilson D; Dhawan S
J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
[TBL] [Abstract][Full Text] [Related]
3. Comparing a novel solubilized benzoyl peroxide gel with benzoyl peroxide/clindamycin: final data from a multicenter, investigator-blind, randomized study.
Kircik L; Green L; Thiboutot D; Tanghetti E; Wilson D; Dhawan S; Parr L
J Drugs Dermatol; 2009 Sep; 8(9):812-8. PubMed ID: 19746673
[TBL] [Abstract][Full Text] [Related]
4. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Draelos ZD; Potts A; Alió Saenz AB;
Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
[TBL] [Abstract][Full Text] [Related]
5. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Gonzalez P; Vila R; Cirigliano M
J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
[TBL] [Abstract][Full Text] [Related]
6. Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris.
Zouboulis CC; Fischer TC; Wohlrab J; Barnard J; Alió AB
Cutis; 2009 Oct; 84(4):223-9. PubMed ID: 19911678
[TBL] [Abstract][Full Text] [Related]
7. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Langner A; Chu A; Goulden V; Ambroziak M
Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
[TBL] [Abstract][Full Text] [Related]
8. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
Callender VD
J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of fixed-combination acne treatment in adolescents.
Gold LS
Cutis; 2013 Mar; 91(3):152-9. PubMed ID: 23617089
[TBL] [Abstract][Full Text] [Related]
10. Clindamycin phosphate 1·2%-benzoyl peroxide 3·0% fixed-dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single-blinded, active-controlled, parallel-group study.
Kawashima M; Hashimoto H; Alió Sáenz AB; Ono M; Yamada M
Br J Dermatol; 2015 Feb; 172(2):494-503. PubMed ID: 25040180
[TBL] [Abstract][Full Text] [Related]
11. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
Cook-Bolden FE
J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Eichenfield LF; Alió Sáenz AB
J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
[TBL] [Abstract][Full Text] [Related]
13. Moderate to severe acne in adolescents with skin of color: benefits of a fixed combination clindamycin phosphate 1.2% and benzoyl peroxide 2.5% aqueous gel.
Eichenfield LF; Krakowski AC
J Drugs Dermatol; 2012 Jul; 11(7):818-24. PubMed ID: 22777222
[TBL] [Abstract][Full Text] [Related]
14. Gender as a clinically relevant outcome variable in acne: benefits of a fixed combination clindamycin phosphate (1.2%) and benzoyl peroxide (2.5%) aqueous gel.
Harper JC
J Drugs Dermatol; 2012 Dec; 11(12):1440-5. PubMed ID: 23377514
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
Dhawan SS
Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and safety results of two topical combination acne regimens.
Kircik LH
J Drugs Dermatol; 2009 Jul; 8(7):624-30. PubMed ID: 19588638
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
Bowman S; Gold M; Nasir A; Vamvakias G
J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized, bilateral comparison of skin irritancy following application of the combination acne products clindamycin/tretinoin and benzoyl peroxide/adapalene.
Goreshi R; Samrao A; Ehst BD
J Drugs Dermatol; 2012 Dec; 11(12):1422-6. PubMed ID: 23377511
[TBL] [Abstract][Full Text] [Related]
19. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
Tanghetti E
Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris.
Akarsu S; Fetil E; Yücel F; Gül E; Güneş AT
J Dermatol; 2012 May; 39(5):433-8. PubMed ID: 22035285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
